After 14 consecutive quarters of net equity sales under Warren Buffett, new CEO Greg Abel has pivoted Omaha from capital hoarding to disciplined offense — deploying $9.7B into OxyChem, $6.8B into Taylor Morrison, $10B into Alphabet, $930M into Bending Spoons, and re-igniting $4.5B of quarterly buybacks while operating earnings compound +16% YoY. Five analyst lenses, three scenarios, four time horizons.
Gray line = BRK.B actual price history from early 2024 ($398) through the May 2, 2025 pre-handover peak ($542.07), the April 16, 2026 succession trough ($464.01), the August 10, 2026 Q2 earnings breakout ($537.74), into October 19, 2026 ($532.02); colored paths = synthesized scenario midpoints forward, probability-weighted (base 50% · bull 25% · bear 25%). Sell-side 12-month targets span $490 (Hold) to $604 (UBS Buy), with Morningstar Fair Value at $587.23.
Those probabilities are a judgment call — so make them yours. Drag to set how likely the bear and bull cases are (base takes the remainder); the blended target below, the dotted line on the chart, and the prob-weighted row of the scenario cards all update live.
Does Berkshire deserve a re-rating as Greg Abel unlocks its $364.7B war chest, or does falling short-term interest income cap the multiple? Each synthesized desk below runs an independent valuation framework.
For 14 quarters Berkshire sat on its hands as cash swelled toward $380B. In H1 2026, Greg Abel flipped the switch: closing $9.7B OxyChem, $6.8B Taylor Morrison, committing $10B to Alphabet, buying $930M of Bending Spoons, and buying back $4.53B of stock in Q2 alone. Swapping 4% T-bills for 12%+ ROIC operating assets adds $8–10B in annual earnings power.
Headline 22× operating P/E is an optical illusion because it penalizes Berkshire for holding $364.7B in low-yielding cash and only counts dividends—not retained earnings—from its $323.8B equity portfolio. Strip out ex-float net cash and credit look-through retained earnings from Apple, AmEx, and Alphabet, and you are paying ~15.8× for world-class rail, energy, and industrial franchises.
With Howard Buffett installed as non-executive Chairman in September 2026 and Greg Abel running operations, the governance architecture is locked in. No private-equity firm or activist can replicate permanent capital that never faces redemptions, regulatory statutory surplus of $333B, and a railroad + interstate grid network with infinite replacement cost.
BRK.B just logged a 10-day winning streak in mid-October 2026—its longest since 2018—pushing RSI(14) to the 79th percentile (62.7) and price to 1.53× book vs. a 10-year median of 1.42×. Meanwhile, the Fed's rate-cutting cycle is already biting: Q2’26 insurance investment income fell 9.1% YoY ($3.06B vs. $3.37B). Every 100 bps drop in T-bill yields clips ~$3.2B pre-tax from the vault.
Buffett hoarded cash because bargains didn’t exist at $1.14T scale; Abel is spending into a slowing economy. Paying $72.50/share ($6.8B) for homebuilder Taylor Morrison and doubling down on Lennar right as U.S. payrolls shed jobs, buying OxyChem ($9.7B) into a commodity trough, and chasing tech via Alphabet ($10B) and Bending Spoons ($930M) smells like style drift just as GEICO’s loss ratio worsens by 480 bps YoY.
| Q2 2026 Operating Ledger (10-Q · Aug 8, ’26) | Q2 2026 | Q2 2025 | YoY Chg | H1 2026 | H1 2025 | Share of Q2 Op Profit |
|---|---|---|---|---|---|---|
| Manufacturing, Service & Retailing (incl. OxyChem) | $4,470M | $3,601M | +24.1% | $7,669M | $6,661M | 34.4% |
| Insurance — Investment Income | $3,059M | $3,367M | −9.1% | $5,738M | $6,260M | 23.6% |
| Insurance — Underwriting (GEICO, Primary, Reins.) | $1,731M | $1,992M | −13.1% | $3,448M | $3,328M | 13.3% |
| BNSF Railway ($6,601M Q2 rev) | $1,558M | $1,466M | +6.3% | $2,935M | $2,680M | 12.0% |
| Berkshire Hathaway Energy (BHE) | $891M | $702M | +26.9% | $2,005M | $1,799M | 6.9% |
| Other (incl. +$326M non-USD debt FX gain) | $1,274M | $32M | n/m | $2,534M | $73M | 9.8% |
| Total Operating Earnings (Non-GAAP) | $12,983M | $11,160M | +16.3% | $24,329M | $20,801M | 100.0% |
| GAAP Net Earnings (incl. $12,684M Q2 inv. gains) | $25,667M | $12,370M | +107.5% | $35,773M | $16,973M | $11.91 / B-sh (Q2) |
Unlike hyper-covered megacap tech, Berkshire is sparsely covered by traditional sell-side desks. Below are published institutional targets and fair-value models sorted low to high against today's $532.02.
Because Berkshire holds no quarterly earnings calls and issues no guidance, traditional broker coverage is thin (MarketBeat tracks 1 Buy and 2 Holds with a $542.50 mean target). However, specialist insurance/conglomerate desks at UBS ($604 Buy, raised post-Q2’26 beat) and intrinsic-value models at Morningstar/InvestingPro (~$587 Undervalued) see 10–14% 12-month upside as Abel’s capital deployment accretes earnings per share.
Synthesized scenario midpoints (mid-year). Returns shown vs. today's $532.02. These are illustrative frameworks, not predictions with certainty — five-year outcomes depend on whether active capital deployment outpaces the drag from lower short-term Treasury yields.
Consolidated cash generation across insurance, rail, energy, and manufacturing (2023–2026E). Note how Berkshire invests ~$19–23B annually in heavy physical capex (BHE grid & BNSF track) while still throwing off $24–30B of free cash flow.
*In FY 2024, reported operating cash flow ($30.6B) and FCF ($11.6B) were temporarily depressed by $28.5B of cash income taxes paid on massive realized Apple stock gains; in FY 2025, operating cash flow rebounded +50.3% to $46.0B and FCF more than doubled to $25.0B (TTM Jun ’26 OCF = $46.6B, Capex = $22.4B, FCF = $24.2B). Total consolidated debt (~$128.6B) is predominantly non-recourse BNSF and BHE utility debt, dwarfed by $364.7B of cash and T-bills (net cash ≈ +$236B).
Per Warren Buffett's and Greg Abel's longstanding rule, GAAP net income swings wildly on unrealized equity mark-to-market gains ($25.7B in Q2’26 alone). The scenario targets are built on clean after-tax Operating EPS per Class B equivalent share.
After dipping 6% in FY25 ($44.49B vs. $47.44B in FY24) on Tough P&C comparisons, Operating EPS has inflected sharply in 2026 (+17.0% YoY in H1’26 to $24.33B, or ~$11.34/B-share in just six months). Our base case models Operating EPS compounding ~9.5%/yr from $23.40 in 2026E to $37.00 by 2031E as operating acquisitions (OxyChem, Taylor Morrison) and steady share buybacks (~1.5%/yr) overpower lower T-bill interest income. At a steady 22.0× exit multiple, $37.00 yields the $815 base-case 5-year target.
Q2 2026 & latest reported YoY growth across Berkshire's operating pillars and capital-deployment frontier — notice how industrial, energy, and capital deployment surged even as insurance float income cooled.
While Q2 insurance investment income dipped 9.1% YoY on lower short-term yields, Berkshire's industrial and energy core is firing on all cylinders: Manufacturing, Service & Retailing jumped +24.1% YoY (bolstered by OxyChem), BHE climbed +26.9% YoY, and gross equity purchases surged more than 5.5× ($39.4B in H1’26 vs. $7.1B in H1’25) alongside $4.53B of Q2 share buybacks.
The entire valuation argument compresses into one disagreement: is Greg Abel unlocking a generational compounding wave from Berkshire's $364.7B vault, or deploying into a late-cycle slowdown while T-bill income rolls over?
Nine structural risks mapped across a 3–5 year horizon. The highest-probability pressure point is T-bill yield compression in the upper-right quadrant, while mega-catastrophe and post-Buffett multiple de-rating sit one row down.
Each 100 bps drop in short-term Treasury yields cuts ~$3.2B of pre-tax interest income off the $324.9B T-bill hoard before Abel can fully redeploy it.
If an early Abel acquisition stumbles, institutional investors could compress BRK.B from 1.53× P/B toward a 1.25–1.30× conglomerate multiple.
Top holdings (Apple, AmEx, BofA, Coca-Cola, Chevron, Alphabet) dominate the $323.8B stock book; a tech or financial drawdown hits book value directly.
GEICO's Q2’26 loss ratio rose 480 bps YoY to 76.6% as it chased policy growth against Progressive; sustained auto-claim inflation squeezes underwriting margins.
Q2’26 BNSF fuel expense jumped 68% YoY ($1,173M vs. $698M); oil spikes in the Strait of Hormuz or rail union wage resets cap operating ratio gains.
A $150B+ industry mega-quake or cyber/hurricane event tests BH Reinsurance and statutory surplus — low odds, but a $10–15B single-quarter hit.
OxyChem ($9.7B), Taylor Morrison ($6.8B), and Lennar (25.9M shares) increase exposure to U.S. housing starts and industrial chemical spreads.
Inverse-condemnation wildfire litigation in Western states threatens regulated utility ROE and could strand BHE’s multi-billion grid capex.
Yen/Euro debt revaluations ($326M gain in Q2’26 vs. $877M loss in Q2’25) and GAAP equity swings create headline volatility for casual observers.
Hover the dotted terms in the metrics, or scan the desk's working definitions for analyzing Berkshire's unique accounting.